1. Home
  2. KEQU vs ANTX Comparison

KEQU vs ANTX Comparison

Compare KEQU & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$34.77

Market Cap

97.9M

Sector

Industrials

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.26

Market Cap

109.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
ANTX
Founded
1906
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.9M
109.6M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
KEQU
ANTX
Price
$34.77
$3.26
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
4.3K
356.9K
Earning Date
03-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
2.09
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.46
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$1.00
52 Week High
$60.89
$6.91

Technical Indicators

Market Signals
Indicator
KEQU
ANTX
Relative Strength Index (RSI) 48.65 49.13
Support Level $33.70 $1.06
Resistance Level $41.26 $6.91
Average True Range (ATR) 0.66 0.33
MACD 0.31 -0.13
Stochastic Oscillator 93.66 27.94

Price Performance

Historical Comparison
KEQU
ANTX

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: